Interestingly, the mesenchymal tumor cells with a CD44+/CD24−/low phenotype could re-establish an epithelial tumor and exhibit drug resistance, which resembled the characteristics of breast CSCs [46]. This evidence concerns the gene CD44 and neoplasm.